id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OGC-2024-0391-0019,EPA,EPA-HQ-OGC-2024-0391,Env Defense-1274511-v1-Final EDSP Fully Executed CD 12-12-24,Supporting & Related Material,Decree,2024-12-12T05:00:00Z,2024,12,,,2024-12-13T01:36:02Z,,0,0,09000064868667e8
EPA-HQ-OGC-2024-0391-0020,EPA,EPA-HQ-OGC-2024-0391,Env Defense-1274513-v1-Final EDSP Fully Executed Settlement Agreement 12-12-24,Supporting & Related Material,"Agreement, Contract",2024-12-12T05:00:00Z,2024,12,,,2024-12-13T01:36:15Z,,0,0,09000064868667e9
EPA-HQ-OGC-2024-0391-0001,EPA,EPA-HQ-OGC-2024-0391,"Proposed Partial Settlement Agreement and Consent Decree, Claim Regarding Implementation of Endocrine Disruptor Screening Program Under the Section 408(p) of the Federal Food, Drug, and Cosmetic Act (FFDCA)",Notice,Consent Decree,2024-10-11T04:00:00Z,2024,10,2024-10-11T04:00:00Z,2024-11-13T04:59:59Z,2024-11-13T02:01:18Z,2024-23633,0,0,09000064867c96f3
EPA-HQ-OGC-2024-0391-0003,EPA,EPA-HQ-OGC-2024-0391,EDSP Proposed Partial Settlement Agreement,Supporting & Related Material,"Agreement, Contract",2024-10-11T04:00:00Z,2024,10,,,2024-10-12T00:39:42Z,,0,0,09000064867b9a1e
EPA-HQ-OGC-2024-0391-0002,EPA,EPA-HQ-OGC-2024-0391,EDSP Proposed Partial Consent Decree,Supporting & Related Material,Decree,2024-10-11T04:00:00Z,2024,10,,,2024-10-12T00:39:55Z,,0,0,09000064867b9a1a